Up 21% from IPO price, ICICI Direct initiates coverage of Data Patterns stock, sees another 25% upside
LIC’s weak listing: Should IPO investors hold, sell stock? Should you buy if you missed IPO? Analysts say this
Paradeep Phosphates Rs 1,500-crore IPO opens today; should you subscribe? Here’s what brokerages say
Share Market LIVE: Sensex rallies 1344 pts, ends above 54300, Nifty at 16259; RIL up 4.4%
Fundraising via IPOs declines 60% in January-March this year
Delhivery IPO share allotment: Check status via BSE, Link Intime, grey market premium; listing on May 24
40 / 1 Mohabewala Industrial Area
Dehradun,
Uttarakhand,
248110
Email : grievance@windlasbiotech.com
Website :www.windlasbiotech.com
Link Intime India Pvt Ltd.
C 101 247 Park LBS Marg Vikhroli (West) Mumbai
BSE, NSE
Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) IIFL Securities Ltd. SBI Capital Markets Ltd
AKW WBL Family Pvt Trust Ashok Kumar Windlass Hitesh Windlass Manoj Kumar Windlass
Issue Open
Issue Close
Listing